Physician

Richard S Kuk, MD

According to 2025 Medicare claims, Richard Kuk, MD (NPI: 1588681316) practices cardiac electrophysiology in the Lynchburg, VA market, with the plurality of this provider's patient population coming from Lynchburg City, VA. This provider's primary affiliated billing organization is CENTRA MEDICAL GROUP, LLC (NPI: 1649228966; TIN: 203639329) and primary practice location at 24501-1109. Kuk is affiliated with the CVACC (ACO ID: A3599), participating under the MSSP model.

Kuk's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,923 traditional Medicare patients, billed 6,444 HCPCS/CPT codes, and received $277,031 in Medicare payments. The top billing code was 93295 (Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days). Part D data shows 1,318 prescription claims across 274 beneficiaries totaling $290,453 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 24 claims. Open Payments data shows 10 records totaling $841. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,852	4,460	$275,717
2016	1,767	4,456	$318,425
2017	1,731	4,684	$340,293
2018	1,596	3,772	$326,057
2019	1,635	4,167	$345,494
2020	2,115	4,658	$353,333
2021	2,443	5,339	$339,351
2022	2,304	6,250	$345,604
2023	2,320	5,716	$287,842
2024	2,923	6,444	$277,031

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	445	3,971	$296,888
2016	451	3,986	$357,028
2017	406	3,475	$322,245
2018	390	2,995	$372,289
2019	410	2,855	$428,193
2020	406	2,616	$516,438
2021	398	2,456	$507,653
2022	354	1,815	$444,768
2023	365	1,686	$405,874
2024	274	1,318	$290,453

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	18	$2,438
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	11	$286
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	24	$1,298
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93295	Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days	280	374	$26
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	671	926	$20
93297	Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days	699	1,481	$19
93298	Evaluation of cardiac rhythm monitor system, remote up to 30 days	468	865	$19
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	775	904	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	183	8,310	$158,930
Xarelto	Rivaroxaban	69	3,360	$60,261
Entresto	Sacubitril/Valsartan	69	2,616	$56,367
Flecainide Acetate	Flecainide Acetate	63	2,738	$1,662
Propafenone Hcl	Propafenone Hcl	16	1,070	$1,048

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$841	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Richard S. Kuk, MD?

Tedicare shows public-source Medicare data for Richard S. Kuk, MD (NPI 1588681316), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard S. Kuk, MD have ACO affiliation data?

Richard S. Kuk, MD is shown with ACO affiliation data for CVACC (MSSP, ACO ID A3599).

What billing organization is linked to Richard S. Kuk, MD?

Richard S. Kuk, MD is linked to CENTRA MEDICAL GROUP, LLC (billing NPI 1649228966) in the available physician profile data.

Does Richard S. Kuk, MD have Open Payments data?

Richard S. Kuk, MD has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.